Asensus Surgical, Inc. (ASXC) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $2.56 million versus the consensus estimate of $3.44 million.
Asensus Surgical, Inc. (ASXC) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $2.56 million versus the consensus estimate of $3.44 million.